Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Roivant Sciences Ltd. | 162,306 | reported | 20 Feb 2025 | tx 97+2,479,491−1,964,891 |
| NeuroPace Inc | 19,160 | reported | 20 Mar 2026 | tx 17+113,010 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2026 | GRANT_AWARD | NeuroPace Inc | 1,153 | 13.00 USD | |
| 19 Dec 2025 | GRANT_AWARD | NeuroPace Inc | 904 | 16.59 USD | |
| 19 Sept 2025 | GRANT_AWARD | NeuroPace Inc | 1,509 | 9.94 USD | |
| 29 Dec 2023 | GRANT_AWARD | NeuroPace Inc | 1,454 | 10.31 USD | |
| 29 Sept 2023 | GRANT_AWARD | NeuroPace Inc | 1,541 | 9.73 USD | |
| 30 Jun 2023 | GRANT_AWARD | NeuroPace Inc | 3,340 | 4.49 USD | |
| 29 Mar 2024 | GRANT_AWARD | NeuroPace Inc | 1,136 | 13.20 USD | |
| 21 Jun 2025 | GRANT_AWARD | NeuroPace Inc | 1,440 | 10.41 USD | |
| 28 Jun 2024 | GRANT_AWARD | NeuroPace Inc | 1,984 | 7.56 USD | |
| 30 Sept 2024 | GRANT_AWARD | NeuroPace Inc | 2,152 | 6.97 USD | |
| 21 Dec 2024 | GRANT_AWARD | NeuroPace Inc | 1,300 | 11.53 USD | |
| 21 Mar 2025 | GRANT_AWARD | NeuroPace Inc | 1,247 | 12.02 USD | |
| 06 Jun 2025 | GRANT_AWARD | NeuroPace Inc | 8,745 | 0.00 USD | deriv |
| 20 Feb 2025 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 958 | 10.72 USD | |
| 13 Feb 2025 | EXERCISE | Roivant Sciences Ltd. | 187,500 | 3.85 USD | |
| 13 Feb 2025 | SALE | Roivant Sciences Ltd. | 227,500 | 10.43 USD | |
| 13 Feb 2025 | EXERCISE | Roivant Sciences Ltd. | 187,500 | 0.00 USD | deriv |
| 20 Jan 2025 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 1,057 | 11.15 USD | |
| 20 Dec 2024 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 3,087 | 11.57 USD | |
| 20 Nov 2024 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 958 | 11.49 USD | |
| 20 Oct 2024 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 956 | 11.92 USD | |
| 23 Sept 2024 | EXERCISE | Roivant Sciences Ltd. | 250,000 | 3.85 USD | |
| 20 Sept 2024 | TAX_WITHHOLDING | Roivant Sciences Ltd. | 3,087 | 11.97 USD | |
| 23 Sept 2024 | SALE | Roivant Sciences Ltd. | 250,000 | 11.89 USD | |
| 23 Sept 2024 | EXERCISE | Roivant Sciences Ltd. | 250,000 | 0.00 USD | deriv |